Table 4. Quality-adjusted discounted... | American Society of Hematology

Table 4.

Quality-adjusted discounted life expectancy, in years, for alternative transplantation strategies

	Transplantation at diagnosis	Transplantation at a fixed time point
Patients, by IPSS risk group	Transplantation at diagnosis		2 years	4 years	6 years	8 years	Transplantation at AML progression
All patients
Low	5.99	6.37	6.98	7.00	7.05^*	6.83
Int-1	4.23	4.41	4.42	4.72	4.89^*	4.87
Int-2	4.53^*	2.99	2.75	2.65	2.65	2.65
High	2.94^*	2.53	2.53	2.53	2.53	2.53
Patients younger than 40 y
Low	5.17	6.16	7.04	7.81	8.47	9.70^*
Int-1	2.29	3.78	5.06	6.16	7.08	9.68^*
Int-2	1.52^*	1.39	1.43	1.44	1.45	1.45
High	—	—	—	—	—	—

	Transplantation at diagnosis	Transplantation at a fixed time point
Patients, by IPSS risk group	Transplantation at diagnosis		2 years	4 years	6 years	8 years	Transplantation at AML progression
All patients
Low	5.99	6.37	6.98	7.00	7.05^*	6.83
Int-1	4.23	4.41	4.42	4.72	4.89^*	4.87
Int-2	4.53^*	2.99	2.75	2.65	2.65	2.65
High	2.94^*	2.53	2.53	2.53	2.53	2.53
Patients younger than 40 y
Low	5.17	6.16	7.04	7.81	8.47	9.70^*
Int-1	2.29	3.78	5.06	6.16	7.08	9.68^*
Int-2	1.52^*	1.39	1.43	1.44	1.45	1.45
High	—	—	—	—	—	—

—indicates insufficient data to perform analysis.

Dominant strategies.